ArticleMalaria journal2025
Clinicians' experience with quinine-based treatment of malaria in the first trimester of pregnancy in Ghana: a phenomenological study.
Article in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn pregnancy, treating malaria with quinine and reducing its adverse effects on pregnant women has posed a significant challenge to clinicians in malaria-endemic areas such as Ghana for over 2-decades. Clinicians' experiences, therefore, play a significant role in clinicians' choices of drugs to safeguard pregnant women. Thus, this study aims to explore clinicians' experiences with quinine-based treatment (QBT) of malaria in early pregnancy in the Tamale Metropolis of Ghana.
methodsAn exploratory qualitative approach, using a phenomenological design, was employed to allow for an in-depth exploration of the experiences of clinicians with QBT during first trimester pregnancy. The data were collected in-between June to July 2023, through key informant interviews with obstetricians/gynaecologists and in-depth interviews with other cadre of healthcare professionals, with a purposive sample of 26 participants, selected across the 2 largest healthcare facilities (Tamale Central Hospital and Tamale Teaching Hospital) in the Tamale Metropolis. The data were audio-recorded, transcribed and manually analysed using thematic analysis.
resultsThe study revealed that clinicians have negative experiences, beliefs, and attitudes towards quinine-based treatment of malaria in pregnancy. Clinicians' experiences include deleterious side effects of quinine, professional norms, and institutional bottlenecks. Participants also encounter challenges related to clinicians and patient concordance, such as patients' beliefs, adherence to review schedules, fears of medico-legal issues, and myths about quinine which affect treatment choices. Participants' attitudes towards malaria treatment include "watchful waiting" and the tension to treat promptly amidst concerns about potential treatment risks. The novel findings of this study were "watchful waiting" and the treatment of uncomplicated malaria in early pregnancy with intravenous artesunate.
conclusionsClinicians' experiences with quinine-based treatment of malaria in pregnancy affect their attitude towards malaria treatment in pregnancy. Most clinicians with experiences of the side effects of quinine and patient negative beliefs about quinine, desist from prescribing it. It is important for the Ministry of Health and the Ghana Health Service to provide feedback systems that allow clinicians to communicate experiences on malaria treatment to policy makers to enable policy review on malaria treatment during pregnancy, particularly in first trimesters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.